Helping clients solve critical and complex challenges, Verista, Inc. is a leading business and technology consultancy firm that provides systems, compliance, validation, and quality solutions to the Life Sciences industry. The company has earned the unwavering trust of its clients by delivering solutions that consistently meet the highest of standards. As a result, it has been awarded Leading Life Sciences Business, Technology and Compliance Solutions Company, USA, in the GHP Global Excellence Awards 2023.
The Life Sciences industry is one of the most challenging and complex business environments. Organisations must be equipped with a high degree of domain expertise and a comprehensive understanding of the intricacies of the product lifecycle. They are responsible for ensuring the safety and efficacy of their products, which ultimately affects peoples’ lives.
For this reason, Life Sciences organisations must be sure that their assets are properly commissioned, qualified, and validated efficiently, while facing the challenges of industry regulations, demanding timelines, and budget constraints. Fulfilling an unmet and ever-evolving need, Verista helps these organisations by facilitating the delivery of compliant, safe, and high-quality medical products.
Verista is dedicated to assisting pharmaceutical, biotech, and medical device organisations, as well as CDMOs, as they work to improve the health and lives of the public. The company works with its clients’ IT, infrastructure, quality, regulatory, and data teams, helping them solve critical challenges across the GxP lifecycle by employing its extensive domain expertise and skilled capability enablement in the areas of Enterprise IT, Lab Informatics, Manufacturing, as well as Regulatory and Compliance.
While large Business Process Organisations (BPOs) and consulting firms are equipped with broad capabilities and rigid processes, Verista has chosen to hone its skills in a niche set of services. This enables the company to act as an extension of its clients’ teams, delivering flexible, focused solutions backed by industry best practices, workflows, and designs.
Furthermore, while Functional Service Providers (FSPs) supply bodies to fulfil a specific function, Verista is equipped with the in-depth understanding needed to provide clients with expert capability enablement in the areas it specialises in.
Prior to the pandemic, it would take many years to bring a molecule from research and development to manufacturing. Now it can take just months. Perceptions of product velocity and speed-to-market have been shattered and the new norm is delivering quality, safe, effective, and compliant products with an accelerated turnaround time. To meet these demands, it is essential that organisations alter their business, operational, and staffing models when it comes to their quality and compliance programmes.
One way in which companies can speed up their processes is by adopting new technologies to digitise paper-based activities. This has become an essential element of a company’s business strategy, however many Life Science organisations still use outdated paper- and spreadsheet-based processes. Verista helps clients better understand where their business is situated on the digital maturity model. It works with them to develop a roadmap to automate and transform their operations by implementing the necessary people, processes, and technologies.
To facilitate this, Verista has fostered strategic partnerships with best-in-class technology companies like Veeva, Kneat, Blue Mountain, ValGenesis, Iron Mountain, and many others. Through this, it helps clients implement systems and achieve greater value from their technology investments. Verista then assists with the management, automation, and validation of their new enterprise and data systems, lab systems, equipment, and manufacturing operations. This helps clients comply with necessary regulations while facilitating faster and smarter operations.
With the services it provides, Verista is spearheading the push towards Pharma 4.0 and digital transformation. For example, it helped a top pharmaceutical company implement Veeva Vault as their Regulatory Information Management System (RIMS), resulting in a faster time to IND submission. They now complete their fully compliant dossiers faster by evaluating and streamlining their processes, meaning their molecules reach the market faster.
In addition, Verista has helped AmplifyBio, a preclinical CRO, implement and validate Blue Mountain and ValGenesis solutions to digitise their asset management activities and convert their paper-based system to a 21 CFR Part 11 compliant electronic system. This eliminated manual handling, mitigating regulatory, quality, compliance, and data integrity risks.
Lastly, Verista implemented and configured a Top 50 pharmaceutical company’s instance of Kneat software for their Computer System Validation (CSV) and Commissioning, Qualification and Validation (CQV) processes. By centralising all their validation activities into a single electronic system, the client was able to streamline their operations, resulting in numerous benefits in relation to quality, efficiency, and cost.
As a result of the excellent services it provides, Verista, Inc. has been awarded Leading Life Sciences Business, Technology and Compliance Solutions Company, USA, in the GHP Global Excellence Awards 2023. We congratulate the company on this applaudable achievement and look forward to seeing what it accomplishes in the years ahead.
For further information, please contact Susan Najjar or visit verista.com
